Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children
NCT02991937 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2022-01-21
Summary
Several prior studies have demonstrated that medical management of acute appendicitis in adults is a safe first-line therapy option. This study aims to determine whether non-operative management of uncomplicated acute appendicitis with antibiotics is non-inferior to operative management in a pediatric population. This study will be a randomized controlled trial comparing non-operative management with antibiotics to surgical management of uncomplicated acute appendicitis. The hypothesis is that antibiotics are not worse than surgery for the treatment of uncomplicated appendicitis in children.
Conditions
- Appendicitis
Interventions
- DRUG
-
Piperacillin/Tazobactam
24 hours of IV antibiotic administration
- PROCEDURE
-
Surgical Treatment
Appendectomy
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jason Fisher, MD · NYU Langone Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2020-12-01
- Completion
- 2020-12-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Antibiotic Safety (SCAMP)
NCT01994993 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
NCT00873327 ·Status: COMPLETED ·Phase: PHASE1
-
Procalcitonin Guided Antibiotic Therapy
NCT04240288 ·Status: WITHDRAWN ·Phase: NA
-
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
NCT01110382 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
NCT04126031 ·Status: TERMINATED ·Phase: PHASE2
-
Antibiotic Prophylaxis for PEG in Children
NCT01870167 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response
NCT02437045 ·Status: COMPLETED ·Phase: PHASE4
-
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
NCT04948463 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a Loading Dose of Vancomycin in Pediatric Dosing
NCT01290237 ·Status: TERMINATED ·Phase: NA
-
Oral-only Antibiotics for Bone and Joint Infections in Children
NCT04563325 ·Status: COMPLETED ·Phase: PHASE4
-
Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer
NCT04637464 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support
NCT03922451 ·Status: TERMINATED
-
Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes
NCT02819570 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics of Piperacillin/Tazobactam in Patients Treated by Continuous Renal Replacement Therapy
NCT00703144 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
NCT02266706 ·Status: COMPLETED ·Phase: PHASE1
-
Initial Oral Antibiotics for Bone and Joint Infections in Children
NCT06827496 ·Status: RECRUITING
-
Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor
NCT01290003 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess
NCT01498744 ·Status: TERMINATED ·Phase: NA
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06672978 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Short-term Antibiotic Therapy for Pyelonephritis in Childhood
NCT00724256 ·Status: TERMINATED ·Phase: PHASE3
-
Piperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas Aeruginosa
NCT01577368 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
NCT06197269 ·Status: COMPLETED ·Phase: NA